Indical Bioscience, Inc

The Florida Department of Agriculture and Consumer Services intends to enter into a single-source agreement with Indical Bioscience, Inc. for specialized testing supplies and reagents compatible exclusively with the IndiMag 2 nucleic acid extraction platform, which are required for USDA and NAHLN-approved diagnostic testing of foreign animal diseases such as Avian Influenza, Foot and Mouth Disease, African Swine Fever, and Newcastle Disease. This procurement is justified under Florida Statutes 120.57(3) and 287.057(3), as Indical Bioscience is the sole provider of these proprietary test kits, making competitive acquisition impossible due to technical and regulatory exclusivity. The contract period runs from July 1, 2026, to June 30, 2027, with an estimated value between $50,000 and $55,000. All deliverables must comply with federal diagnostic standards and be suited for use within the Division of Animal Industry’s testing protocols in Florida. No formal FAR contract clauses apply; instead, the acquisition follows state procurement rules and relies on the referenced PUR 7776 document for detailed specifications. The solicitation number is SS 26 27 33, and responses must be submitted to Edward Rondeau by July 23, 2026, via email or mail. While the place of performance is Florida, no specific delivery location, FOB terms, packaging standards, inspection criteria, or invoicing procedures are outlined in the available materials. The contracting officer is Edward Rondeau, with no designated COR or COTR identified. There are no specified evaluation factors, socioeconomic certifications, UEI or CAGE codes, or option periods, and no detailed line-item pricing, CLIN structure, or quality assurance protocols are provided beyond the requirement for USDA/NAHLN compliance.